about
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaIntracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction.Cancer drug resistance: redox resetting renders a wayModification by ubiquitin-like proteins: significance in apoptosis and autophagy pathwaysQuantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantationArsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative StressLow-Concentration Arsenic Trioxide Inhibits Skeletal Myoblast Cell Proliferation via a Reactive Oxygen Species-Independent PathwayReactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosisArsenic, asbestos and radon: emerging players in lung tumorigenesisRetinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cellsArsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6Factors determining sensitivity and resistance of tumor cells to arsenic trioxideAlterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myelomaNano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoApoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activitiesKML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress PathwayHeavy metal toxicity and the environmentInhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.Identification of arsenic-binding proteins in human breast cancer cellsInhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancerTargeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.The protein Nalpha-terminal acetyltransferase hNaa10p (hArd1) is phosphorylated in HEK293 cells.Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cellsArsenic trioxide induces apoptosis of human gastrointestinal cancer cells.Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity.BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximineOncogenomic disruptions in arsenic-induced carcinogenesis.Enhanced glutathione biosynthetic capacity promotes resistance to As3+-induced apoptosis.WIP1 phosphatase as pharmacological target in cancer therapy.Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersThe herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.Arsenic trioxide modulates DNA synthesis and apoptosis in lung carcinoma cells.Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cellsArsenic(III) species inhibit oxidative protein folding in vitro.Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growthCytotoxicity and oxidative stress in human liver carcinoma cells exposed to arsenic trioxide (HepG(2)).
P2860
Q24317497-07BE3416-E89A-42FC-81B4-841CC16DAFE9Q24605527-70108F77-3C06-4987-8A61-E2D26AFBCAF7Q24813110-421ADD20-224D-4B28-9A3B-D4584A2B6972Q26750753-93FF3FCB-C559-48A9-B4F2-A74A34FB27D3Q27011543-3F3F4523-BECC-4775-A0F2-C1BC5042891BQ27333786-511C9FF9-060B-4F62-9B19-B9A348BECDCFQ27487944-289D773B-64E9-464A-AA94-A2F12B76A7F7Q28388442-0B8D6980-57F6-4DA2-ABC6-F98B1845392DQ28388476-87B01CE9-3D7D-44A2-A405-8D15ED2D542EQ28392539-E3E3CF91-E943-4F79-BB35-9345946CF223Q28393380-E864B4B3-B170-4563-AD9B-DA1B7899F384Q28481142-788E1B8F-ACF6-4C99-BDEF-6CAD7EB301F0Q28483625-9191EFB6-E1AF-405D-B3CA-E2002358881AQ28484542-8CD9A2C1-5AEB-48E6-9723-D4083FC2F1A6Q28488457-FCB793E9-08CC-4C26-BCB0-0F4D7C441145Q28542724-C205A8A1-1EDE-4B43-BCF0-B71C640F3AF7Q28547789-B3EB8AD7-1A54-49EF-A59E-E926F65114E2Q28654255-59F610A3-583C-475D-B197-FC2B1D33B099Q30436959-FA1C0BE0-CACB-40B9-85C7-BC89085E1859Q30831628-755CBE7B-CA7E-4D20-A9B4-26D2002FF238Q33258696-11875EA6-4022-4EF0-9507-24C633127EE1Q33291299-41A9D436-BD99-4DE6-B38B-919529C612E1Q33312494-DD7F740B-3E5D-49F6-8E9A-189B988F888DQ33418000-3D82F7F8-EBFC-4E10-BA3D-FF8E60524439Q33470967-7D54A2CB-3139-40F8-86D4-2387E195AE35Q33474444-CBF72057-9602-4F65-A9BE-BD96A7727E1EQ33594955-5CE1F16C-253F-4DFA-8E7E-780CB605F4FFQ33598739-36799560-F02F-4207-B6E2-84B1D90DD0D8Q33642685-1618D430-C61C-4663-9865-398CE63230C8Q33649020-6678D964-F51F-4DBE-BA45-543B629D77F5Q33653912-075EE730-38C2-4F53-9210-2323C0EA52E4Q33720757-1FE4005C-C78D-44CD-8E63-96137D2F7092Q33768666-A2D69E51-27AF-4A68-A660-D80D485D5449Q33815705-9F85249A-907B-42E5-AEA4-2D82C7ED1BD3Q33827724-B87F4C0F-1BD0-4FC4-97F6-9813E1B4CBD1Q33862077-DC37DA15-5CA5-4E44-B371-36171085CBA8Q33965775-F1F0FA47-5F1A-4E61-8DFE-FE4151D7DC04Q33968624-BB6340B4-CBDF-484D-9AB2-3F166EEE1F26Q33976179-97A352BE-FD0B-4CD2-9152-E272C0A8263CQ34013665-B7D4F943-075D-42A3-95E1-B8C0CEEDB934
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms of action of arsenic trioxide.
@ast
Mechanisms of action of arsenic trioxide.
@en
Mechanisms of action of arsenic trioxide.
@nl
type
label
Mechanisms of action of arsenic trioxide.
@ast
Mechanisms of action of arsenic trioxide.
@en
Mechanisms of action of arsenic trioxide.
@nl
prefLabel
Mechanisms of action of arsenic trioxide.
@ast
Mechanisms of action of arsenic trioxide.
@en
Mechanisms of action of arsenic trioxide.
@nl
P2093
P1433
P1476
Mechanisms of action of arsenic trioxide
@en
P2093
Hyman M Schipper
Jack Singer
Janet S Lee
Samuel Waxman
Wilson H Miller
P304
P407
P577
2002-07-01T00:00:00Z